GlobeNewswire

Minerva Neurosciences Provides Third Quarter 2026 Financial Results and Business Updates
06/11/2026
Confirmatory Phase 3 trial of roluperidone (MIN-101C19) ongoing with topline efficacy data expected 2H 2027 Recent Schizophrenia Research article describes need to expand basic science beyond dopaminergic mechanisms and [...]
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
06/11/2026
Bria-OTS+™ demonstrates broad immune activation and sustained cancer-cell killing across multiple tumor models BriaPro data highlights BP-80 tolerability in primates and advances in tumor-targeted checkpoint inhibition [...]
IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Immunity in Advanced Ovarian Cancer
06/11/2026
Analysis of paired patient biopsies from the randomized Phase 2 OVATION 2 study shows IMNN-001 increased CD8+/Treg, CD8+/CD4+ and CD8+/IDO+ ratios in both tumor and stroma Findings provide an immunological mechanism for [...]
MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)
06/11/2026
Colorectal cance r: in a human liver-metastasis organoid model resistant to botensilimab and balstilimab alone, the addition of agenT-797 supported immune reprogramming and tumor-cell killing, reinforcing the rationale [...]
TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12
06/11/2026
FREDERICK, Md., Nov. 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced it will reschedule its conference call [...]
Le KFSH de Riyad obtient la distinction « Global Elite Five-Star » de Davos Healthcare et figure parmi les 5 % des hôpitaux les mieux évalués au monde
06/11/2026
RIYAD, Arabie saoudite, 06 nov. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) de Riyad s’est vu décerner la médaille « Global Elite Five-Star » par Davos Healthcare, la plus [...]
HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer
06/11/2026
Designated as one of the Top 150 abstracts submitted for the 41 st Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class, second-generation, tetravalent pembrolizumab (Keytruda®) based [...]
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
06/11/2026
Detection of neoantigen-specific T cells directly ex vivo indicates strong EVX-01-induced immune responses Data further underlines the strong predictive performance of Evaxion’s AI-Immunology™ platform The new biomarker [...]
Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
06/11/2026
RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release [...]
Eccogene to Present Preclinical Data of Small Molecule Amylin and Calcitonin Receptor Agonist ECC1542 at ObesityWeek® 2026
06/11/2026
Poster presentation will highlight the preclinical profile of ECC1542 and its potential for treating obesity and associated comorbidities BOSTON and SHANGHAI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Eccogene, a global [...]
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings
06/11/2026
WATERTOWN, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal [...]
Spectral Medical Announces Third Quarter 2026 Financial Results and Provides Corporate Update
06/11/2026
• Recent financing expected to fund operations through anticipated FDA PMA decision • Company to host a Corporate Update call December 10, 2026 TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
BEDFORD, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
06/11/2026
CAMBRIDGE, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ® ) platform to [...]
Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
06/11/2026
BURLINGTON, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity [...]
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
06/11/2026
Fat fraction, together with clinical endpoints, may support a potential accelerated approval pathway for forazapadin Protocol amendment submitted to implement the new primary efficacy endpoint Topline 12-week placebo- [...]
What Do Healthcare Sharing Programs Actually Cover, and What They Don’t
06/11/2026
Eligibility guidelines are where healthcare sharing programs differ most, especially for pre-existing conditions, routine care, mental health, maternity, and prescriptions. WeShare Health begins sharing pre-existing [...]
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
06/11/2026
New solution for 5ᵗʰ metatarsal deformities further broadens portfolio and provides access to incremental surgical procedures PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” [...]
Anika Reports Third Quarter 2026 Financial Results
06/11/2026
Revenue Increased 10% Year Over Year, Led by 17% Commercial Channel Growth Including More Than 30% Growth in Integrity TM Revenue Secured New 10-Year Hyvisc® Partnership with Enhanced Economics; Reintroduced Hyaff Non- [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum